Disease, Illness and Condition Library


    Tuberculosis

    Labeled the “Captain of all these Men
    of Death” by John Bunyan in 1680,
    tuberculosis or T.B has been found
    on all continents and in all civilizations
    throughout history. It afflicted the early
    Egyptians, ancient Andean tribes
    in South America, and early Indian
    tribes of North America.

    While always present to some degree,
    the disease has at times caused prolonged
    epidemics, some stretching over many
    centuries. Europe and North America are
    at the end of a 300-400 year epidemic
    cycle which at its peak resulted in the
    death of 10 to 15 percent of the population.
    Due presumably to the acquisition of the
    herd immunity (group resistance to an infection), to incidental improvements
    in living conditions in terms of crowding, hygiene, and nutrition, and to deliberate
    human intervention (including isolation of infectious causes and the development
    of effective drug therapy), the incidence of the disease waned steadily in these
    regions over the past 100 years.

    By contrast, tuberculosis is epidemic now in most of African and Asia, with
    attack rates in some countries 100 times higher than rates in the United States
    and Europe. However, beginning in 1986, public health officials started to
    become aware of a distinct resurrection of Tuberculosis in the United States,
    particularly in the nations inner cities. This trend has continued and in 2007
    there were a couple of high profile TB cases which made front page news.

    In general, the epidemic cycles of tuberculosis has resulted from the
    introduction of the infecting organism into a population that is relatively
    more vulnerable because of genetically determined aspects of immunity
    as well as aggravating environmental factors, such as poor housing and
    overcrowding, malnutrition, and poor sanitation. Unlike the influenza virus,
    which can cause global recurring epidemics by means of viral mutations that
    circumvent previously acquired immunity, the tuberculosis microorganism
    does not appear to have undergone significant biological modifications to
    promote its prevalence.

    However, the appearance of the AIDS epidemic threatens to have a massive
    impact on the prevalence of tuberculosis throughout the world.

    The Germ

    Tuberculosis is a chronic wasting disease that primarily attacks the lungs,
    although it can also affect other parts of the body. It can be fatal if not treated.
    Tuberculosis is caused by a type of bacterium (a bacillus) that belongs to a
    highly unusual family of microbes, the mycobacteria. The cell walls of
    mycobacteria are substantially different from those of most other disease
    causing bacteria, such as staphylococci or streptococci. Instead of being
    composed largely  of carbohydrates and proteins, mycobacterial cell walls are
    composed largely of lipids, or waxes. And in contrast to most bacteria, which
    multiply under suitable circumstances in as little as 12 to 20 minutes,
    Mycobacterium tuberculosis requires roughly 24 hours to replicate. The basic
    attributes play prominent roles in the transmission and course of the disease.

    The chemical structure of the cell walls of M. tuberculosis means that the body’s
    usual mechanisms of defense against bacterial infections – antibodies and
    polymorphonuclear leukocytes, the type of white blood cells that fight off acute
    infective agents – are largely ineffective. The barrier provided by its cell wall
    also makes the tubercle bacillus resistant to most standard antibiotics.

    The slow replication rate means that there is a substantial incubation time
    between the primary infection and the manifestations of illness – a few months
    at minimum and commonly many years. Further complicating the control of
    tuberculosis is the extraordinarily long period required for a cure:
    6 to 18 months of continuous medication. This is due both to the relative
    resistance of M. tuberculosis to standard antibiotics and its indolent metabolism
    and replication rate. (Bacteria are most vulnerable to antibiotics while they
    multiply.)

    Transmission and Immunity

    Tuberculosis is spread almost exclusively by human to human aerosol
    transmission of the bacilli. A patient with pulmonary tuberculosis (tuberculosis
    of the lungs), the most common form of the disease, coughs the bacilli into the
    air to be inhaled by someone else. Unlike some of the virulent, aggressive
    respiratory infections that may invade the body through the lining of the upper
    airways. Tuberculosis can take hold only if the bacilli are inhaled deep into the
    lungs, into the microscopic air sacs called alveoli. Once the bacilli reach the
    alveoli, the battle between host and parasite commences.

    Even though the classic antibody defense system does not offer significant
    protection against tuberculosis, humans have evolved a modestly successful
    defense: cell-mediated immunity, in which a team of specialized cells of the
    immune system, macrophages and T-lymphocytes, combine to inhibit
    replication of the bacilli.

    Macrophages (literally, “large eaters”) may reasonably be compared to figures
    in the popular video game of the 1970’s fame, Pac-Man. Macrophages patrol
    many of the tissues of the body, alert the presence  of foreign material, both
    organic and inorganic. Their response on encountering a tubercle bacillus is to
    engulf it. However, the macrophage by itself does not fare well in its battle with
    the mycobacterium. In order to exert a significant inhibitory effect on the
    organism’s survival and replication, the macrophage requires assistance from
    two types of T-lymphocytes, helper and killer T-cells. Once activated by
    chemical interaction with these T-cells, macrophages can curtail the growth
    and spread of the bacilli.

    In most immunologically normal people, tuberculosis never takes hold: Of 100
    people infected with the bacilli, only 10 will come down with the disease during
    their lifetime. In the others, the bacilli will lie dormant in the lungs and other
    tissues, producing no symptoms.
    This is called latent tuberculosis. Sometimes, however, the cell-mediated
    immunity system fails, and the bacilli multiply and spread throughout the
    body. They lodge in a variety of organs and ultimately may cause progressive
    infection and destruction of vital tissue. Although the great preponderance of
    tuberculosis cases involves the lungs, 5 to 20 percent of cases involve other
    parts of the body, such as the lymph nodes, kidneys, bones, or central nervous
    system. Among AIDS patients the percentage of cases in which organs or
    tissues outside the lungs are affected is much higher, ranging up to
    65 percent.

    AIDS and Tuberculosis

    Unfortunately, the human immunodeficiency virus (HIV), the virus that causes
    AIDS, destroys “helper” T-cells. Thus, patients with HIV infection are rendered
    incapable of mounting or sustaining an effective defense against tuberculosis
    (and many other infections against which the major defense is cell-mediated
    immunity). Most cases of tuberculosis seen among HIV infected individuals
    represent reactivation of a latent tuberculosis infection which antedated the
    HIV infection, often by decades.

    Tragically, the epidemiological patterns of HIV and tuberculosis infections
    demonstrate considerable overlap. In many of the nations of sub-Sahara Africa,
    the march of HIV through the population has been shadowed by exploding rates
    of tuberculosis. Similar parallel epidemics are being witnessed among the inner
    city population of the United States, where high rates of HIV infection coincide
    with other factors that increase the risk of getting TB, including homelessness,
    drug use, alcoholism, malnutrition, and the presence of immigrants from
    countries where TB rates are high.

    Medical authorities anticipate that as HIV infection spreads, the incidence of
    tuberculosis worldwide will rise substantially. In recent years there have been
    approximately 10 million new cases of TB and 3 million deaths from the disease
    annually worldwide-without a major contribution from HIV infection rates in
    Africa, the United States, and Brazil.  The biggest disaster could occur if AIDS
    becomes widespread in Asia, where, in addition to a very high prevalence of
    latent tuberculosis, there is severe over crowding, which could promote a rapid
    spread of tuberculosis even to those without HIV infection.


    Helpful Natural Supplements for Tuberculosis

Symptoms of Pulminary Tuberculosis

  • persistent cough

  • fever

  • night sweats

  • extreme fatigue

  • chest pain

  • hemoptysis (coughing blood)
Purchase Remedies
Home
Library Index
Additional Library
Resources